Pharmacokinetic, bacteriological and clinical aspects on the use of doxycycline in patients with active duodenal ulcer associated with Campylobacter pylori.
about
Guinea pig model for antibiotic transport across gastric mucosa: inhibitory tissue concentrations of clindamycin against Helicobacter pylori (Campylobacter pylori) following two separate dose regimens.Role of metronidazole resistance in therapy of Helicobacter pylori infections.Gastric penetration of amoxicillin in a human Helicobacter pylori-infected xenograft model.Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cellsLansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori.
P2860
Pharmacokinetic, bacteriological and clinical aspects on the use of doxycycline in patients with active duodenal ulcer associated with Campylobacter pylori.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh-hant
name
Pharmacokinetic, bacteriologic ...... ted with Campylobacter pylori.
@en
Pharmacokinetic, bacteriologic ...... ted with Campylobacter pylori.
@nl
type
label
Pharmacokinetic, bacteriologic ...... ted with Campylobacter pylori.
@en
Pharmacokinetic, bacteriologic ...... ted with Campylobacter pylori.
@nl
prefLabel
Pharmacokinetic, bacteriologic ...... ted with Campylobacter pylori.
@en
Pharmacokinetic, bacteriologic ...... ted with Campylobacter pylori.
@nl
P1476
Pharmacokinetic, bacteriologic ...... ated with Campylobacter pylori
@en
P577
1988-01-01T00:00:00Z